RxDoctor Payments DataLook up a doctor →

Melissa Frank

Gerontology · Melbourne, FLNPI 1487868782

Payments from drug & device makers

$9,564in general payments, 2019–2025

Across 537 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$776
  • AstraZeneca$756
  • Pfizer$568
  • Amgen$557
  • Boehringer Ingelheim$531
  • plus $5K from 34 others

What the payments were for

  • Food & beverage$9,47599%
  • Education$891%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,564 in reported general payments places this provider in the 95th percentile of 714 gerontology providers in Florida.

See all gerontology providers in Florida

Medicare billing

Part B allowed, 2024
$94,539
Medicare patients
296
Services billed
1,349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide59$110,144
JardianceEmpagliflozin27$37,115
TrulicityDulaglutide31$36,429
EliquisApixaban20$33,481
XareltoRivaroxaban13$15,049
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$11,118
VascepaIcosapent Ethyl16$10,916
FarxigaDapagliflozin Propanediol14$10,888
Icosapent Ethyl11$4,953
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$4,023
Losartan Potassium263$3,406
Atorvastatin Calcium271$3,111
Rosuvastatin Calcium173$2,995
Omeprazole150$2,971
Metoprolol Succinate112$2,048

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,806$110,14459 claims
Boehringer IngelheimJardiance$531$37,11527 claims
Lilly USA, LLCTrulicity$503$36,42931 claims
PfizerEliquis$568$33,48120 claims
Johnson & JohnsonXarelto$156$15,04913 claims
GSKAnoro Ellipta$437$11,11817 claims
AstraZenecaFarxiga$756$10,88814 claims
AbbVieSynthroid$776$1,27311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 714 gerontology providers in Florida.

Other gerontology in Melbourne

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →